BMO Capital Markets upgrades Everest Group stock to Outperform, citing potential reserve charge and management change as ...

A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.

The Juna Akhada Pandal at Mahakumbh 2025 has been completed in a remarkable 35 days, covering an area of 4.75 lakh square ...

As an industry leader, Huasun has made significant strides through innovation and market expansion. This not only reflects Huasun’s drive for progress but also serves as a vivid testament to ...

Everest Industries Ltd. key Products/Revenue Segments include Building Products, Income From Contracts, Traded Goods, Scrap, Other Operating Revenue, Other Items, Export Incentives for the year ending ...